M
Michael P. Sherman
Researcher at University of Missouri
Publications - 102
Citations - 5928
Michael P. Sherman is an academic researcher from University of Missouri. The author has contributed to research in topics: Cardiopulmonary bypass & Necrotizing enterocolitis. The author has an hindex of 38, co-authored 102 publications receiving 5664 citations. Previous affiliations of Michael P. Sherman include UCLA Medical Center & Southern Illinois University School of Medicine.
Papers
More filters
Journal Article
Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide.
TL;DR: There is a correlation between ameboid microglial cell killing of oligodendrocytes and NO2- production suggesting NO may be a mechanism of death of the oligodendedrocyte and possibly play a role in lesion formation in multiple sclerosis.
Journal ArticleDOI
Amniotic fluid: not just fetal urine anymore.
TL;DR: Current understanding of the origin and circulation of AF and its nutritive, protective, and diagnostic functions are reviewed and future directions for AF research are discussed.
Journal ArticleDOI
Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury
TL;DR: Administration of either the antioxidants mercaptopropionyl glycine and catalase or the NO synthase inhibitor, NG-nitro-L-arginine methyl ester, to the extracorporeal circuit afforded similar and nearly complete protection against myocardial reoxygenation injury.
Journal ArticleDOI
Nitric oxide is an important mediator for tumoricidal activity in vivo
TL;DR: It is demonstrated that nitric oxide is an important mediator of host resistance to syngeneic and xenogeneic ovarian tumor grafts in C3HeB/FeJ mice and tumoricidal activity was reduced by inhibition of Nitric oxide synthesis.
Journal ArticleDOI
Pyrrolidine Dithiocarbamate Inhibits Induction of Nitric Oxide Synthase Activity in Rat Alveolar Macrophages
TL;DR: Findings suggest iNOS activity in macrophages treated with LPS + IFN gamma requires NF-kappa B activation, and Pyrrolidine dithiocarbamate added to cultured macrophage stimulated with lipopolysaccharide and interferon-gamma suggests this requirement.